Gemcitabine/Abraxane Chemotherapy And Dose Escalated Radiotherapy For Locally Advanced, Unresectable Pancreatic Cancer
Posted Date: May 15, 2019
- Investigator: Olugbenga Olowokure
- Type of Study: Drug
Patients will get gemcitabine combined with Abraxane, then gemcitabine in combination with radiation therapy. Abraxane is a chemotherapy drug that may help treat pancreatic cancer by allowing gemcitabine to further penetrate the tumor in the pancreas. This study will analyze the good and bad effects
Criteria:
Eligible Patients Must Have A Confirmed Diagnosis Of Adenocarcinoma Of The Pancreas, Locally Advance
Keywords:
Gastrointestinal Can, Gi Cancer, Pancreatic Cancer, Ucci-Gi-01, Unresectable
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu